Literature DB >> 9694870

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer.

L J Jonk1, S Itoh, C H Heldin, P ten Dijke, W Kruijer.   

Abstract

Smad proteins have been identified as mediators of intracellular signal transduction by members of the transforming growth factor-beta (TGF-beta) superfamily, which affect cell proliferation, differentiation, as well as pattern formation during early vertebrate development. Following receptor activation, Smads are assembled into heteromeric complexes consisting of a pathway-restricted Smad and the common Smad4 that are subsequently translocated into the nucleus where they are thought to play an important role in gene transcription. Here we report the identification of Smad Binding Elements (SBEs) composed of the sequence CAGACA in the promoter of the JunB gene, an immediate early gene that is potently induced by TGF-beta, activin, and bone morphogenetic protein (BMP) 2. Two JunB SBEs are arranged as an inverted repeat that is transactivated in response to Smad3 and Smad4 co-overexpression and shows inducible binding of a Smad3- and Smad4-containing complex in nuclear extracts from TGF-beta-treated cells. Bacterial-expressed Smad proteins bind directly to the SBE. Multimerization of the SBE creates a powerful TGF-beta-inducible enhancer that is also responsive to activin and BMPs. The identification of the sequence CAGACA as a direct binding site for Smad proteins will facilitate the identification of regulatory elements in genes that are activated by members of the TGF-beta superfamily.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694870     DOI: 10.1074/jbc.273.33.21145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  154 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta.

Authors:  Ester Piek; Maarten Van Dinther; W Tony Parks; John M Sallee; Erwin P Böttinger; Anita B Roberts; Peter Ten Dijke
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

3.  Bcr-Abl activates the AKT/Fox O3 signalling pathway to restrict transforming growth factor-beta-mediated cytostatic signals.

Authors:  Azeddine Atfi; Lucile Abécassis; Marie-Francoise Bourgeade
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

4.  Smad4 deficiency impairs chondrocyte hypertrophy via the Runx2 transcription factor in mouse skeletal development.

Authors:  Jianyun Yan; Jun Li; Jun Hu; Lu Zhang; Chengguo Wei; Nishat Sultana; Xiaoqiang Cai; Weijia Zhang; Chen-Leng Cai
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

5.  BMP enhances transcriptional responses to NGF during PC12 cell differentiation.

Authors:  P Lönn; K Zaia; C Israelsson; S Althini; D Usoskin; A Kylberg; T Ebendal
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

6.  Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

Authors:  Ludovic Vallier; Sasha Mendjan; Stephanie Brown; Zhenzhi Chng; Adrian Teo; Lucy E Smithers; Matthew W B Trotter; Candy H-H Cho; Amelie Martinez; Peter Rugg-Gunn; Gabrielle Brons; Roger A Pedersen
Journal:  Development       Date:  2009-03-11       Impact factor: 6.868

7.  Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.

Authors:  Xue-Bin Wu; Yanan Li; Adina Schneider; Wanqin Yu; Gopalan Rajendren; Jameel Iqbal; Matsuo Yamamoto; Mohammad Alam; Lisa J Brunet; Harry C Blair; Mone Zaidi; Etsuko Abe
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  IPF pathogenesis is dependent upon TGFβ induction of IGF-1.

Authors:  Danielle M Hernandez; Jeong-Han Kang; Malay Choudhury; Mahefatiana Andrianifahanana; Xueqian Yin; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

9.  Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.

Authors:  Kenji Ogawa; Feifei Chen; Chenzhong Kuang; Yan Chen
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

10.  Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.

Authors:  Daizo Koinuma; Shuichi Tsutsumi; Naoko Kamimura; Hirokazu Taniguchi; Keiji Miyazawa; Makoto Sunamura; Takeshi Imamura; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.